课题基金 / 基金详情

Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID-19 disease expression and development of therapeutics

Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID-19 disease expression and development of therapeutics
SARS-CoV-2 受体 ACE2 的遗传变异对 COVID-19 疾病表达和治疗方法开发的贡献
批准号:
429441
负责人:
Haas Kurt
金额:
$12.56万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-05-01 至 2021-05-01

项目摘要

项目成果

Haas Kurt的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The coronavirus causing the COVID-19 pandemic infects by binding to a receptor called ACE2 on the surface of cells lining the lung. One reason for the virulence of this new virus is the strength of its binding to ACE2. However, one of the leading mysterie
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID-19 disease expression and development of therapeutics
  • 批准号:
    442865
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Haas Kurt
  • 依托单位:
Imaging neural circuit dynamics in the awake developing brain: Identifying origins of neurodevelopmental disorders
  • 批准号:
    334295
  • 项目类别:
    Operating Grants
  • 资助金额:
    $233.74万
  • 财政年份:
    2015
  • 负责人:
    Haas Kurt
  • 依托单位:
Dual in vivo imaging of morphological and functional refinement underlying experience-driven improvement of neuronal encoding
海外基金